Abstract
Lung cancer comprises of two major clinically relevant types, non-small cell lung cancer (NSCLC) representing about 85% of all cases and small cell lung cancer (SCLC) accounting for the remaining 15%. Despite recent advancements that include new understanding of the molecular mechanisms involved in cancer pathogenesis and introduction of new treatments, lung cancer continues to reign as the leading cause of cancer deaths worldwide. Innovations in genomics-based technologies are becoming rapidly integrated into lung cancer research and the results of these efforts have started to yield tangible advances in improved understanding and treatment of lung cancer.
Keywords: Lung cancer, oncogene, cancer stem cell, stroma, cancer-associated fibroblasts, genomics, biomarkers, personalized medicine, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC)
Current Respiratory Medicine Reviews
Title: Genomic and Cellular Pathology of Lung Cancer
Volume: 7 Issue: 5
Author(s): Sandy D. Der, Roya Navab, Kota Ishizawa and Ming-Sound Tsao
Affiliation:
Keywords: Lung cancer, oncogene, cancer stem cell, stroma, cancer-associated fibroblasts, genomics, biomarkers, personalized medicine, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC)
Abstract: Lung cancer comprises of two major clinically relevant types, non-small cell lung cancer (NSCLC) representing about 85% of all cases and small cell lung cancer (SCLC) accounting for the remaining 15%. Despite recent advancements that include new understanding of the molecular mechanisms involved in cancer pathogenesis and introduction of new treatments, lung cancer continues to reign as the leading cause of cancer deaths worldwide. Innovations in genomics-based technologies are becoming rapidly integrated into lung cancer research and the results of these efforts have started to yield tangible advances in improved understanding and treatment of lung cancer.
Export Options
About this article
Cite this article as:
D. Der Sandy, Navab Roya, Ishizawa Kota and Tsao Ming-Sound, Genomic and Cellular Pathology of Lung Cancer, Current Respiratory Medicine Reviews 2011; 7 (5) . https://dx.doi.org/10.2174/157339811797189740
DOI https://dx.doi.org/10.2174/157339811797189740 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Perspectives in Engineered Mesenchymal Stem/Stromal Cells Based Anti- Cancer Drug Delivery Systems
Recent Patents on Anti-Cancer Drug Discovery New Vascular Disrupting Agents in Upper Gastrointestinal Malignancies
Current Medicinal Chemistry Identification of Differentially Expressed Gene Using Robust Singular Value Decomposition
Current Bioinformatics Innovative Drug Delivery Systems for the Administration of Natural Compounds
Current Bioactive Compounds New Developments in the Management of Pleural Effusions
Current Respiratory Medicine Reviews Gender Differences in Cancer-associated Venous Thromboembolism
Current Medicinal Chemistry Targeting the NF-κB pathway in prostate cancer: a promising therapeutic approach?
Current Drug Targets Alternative and New Radiopharmaceutical Agents for Lung Cancer
Current Radiopharmaceuticals Current Development of ROS-Modulating Agents as Novel Antitumor Therapy
Current Cancer Drug Targets Dysregulation of LncRNAs in Placenta and Pathogenesis of Preeclampsia
Current Drug Targets Analysis of the Differences in the Expression of mRNAs and miRNAs Associated with Drug Resistance in Endometrial Cancer Cells Treated with Salinomycin
Current Pharmaceutical Biotechnology Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer
Anti-Cancer Agents in Medicinal Chemistry A Content-based Image Retrieval Scheme for Lung Nodule Classification
Current Medical Imaging Cabozantinib in Thyroid Cancer
Recent Patents on Anti-Cancer Drug Discovery Autophagy and Ubiquitination as Two Major Players in Colorectal Cancer: A Review on Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Meet Our Editorial Board Member:
The Natural Products Journal Chemomodulating Effects of Flavonoids in Human Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Role of EGFR Monoclonal Antibodies in the Management of Non–small Cell Lung Cancer
Current Cancer Drug Targets Editorial (Hot Topic: Development of New Molecular Agents Targeting Key Signalling Pathways Activated by Growth Factors in Human Cancer)
Current Pharmaceutical Design Role of Infrared Spectroscopy and Imaging in Cancer Diagnosis
Current Medicinal Chemistry